Prospective analysis of office-based hysteroscopic sterilization

Mark D. Levie, Scott G. Chudnoff

Research output: Contribution to journalArticle

60 Citations (Scopus)

Abstract

STUDY OBJECTIVES: To evaluate the efficacy of performing the Essure hysteroscopic sterilization in an office-based setting. DESIGN: Prospective, longitudinal analysis (Canadian Task Force classification II-3). SETTING: University out-patient office. PATIENTS: All patients undergoing permanent sterilization in our outpatient office who opted for hysteroscopic sterilization were included. INTERVENTIONS: Hysteroscopic placement of the Essure device in an office-based setting with only non-steroidal antiinflammatory drugs and paracervical block. MEASUREMENTS AND MAIN RESULTS: Multiple data points were collected on each patient including demographic data, specific procedural information, and 12-week hysterosalpingogram data. Most of our patients were Hispanic and had an average body mass index of 30.3. Average time to perform the procedure was 12.4 minutes, with the steepest improvement in the first 13 cases. Bilateral placement of the device was successful in 98 (96%) of 102 patients. Of these patients 92 have 12-week hysterosalpingography results (6 patients were lost to follow-up), with 90 (98%) showing bilateral tubal occlusion. There were no intraprocedural or postprocedural complications. CONCLUSION: In our institution and in our experience, office-hysteroscopic placement of the Essure device is a feasible and effective approach for permanent sterilization.

Original languageEnglish (US)
Pages (from-to)98-101
Number of pages4
JournalJournal of Minimally Invasive Gynecology
Volume13
Issue number2
DOIs
StatePublished - Apr 2006

Fingerprint

Equipment and Supplies
Outpatients
Hysterosalpingography
Obstetrical Anesthesia
Tubal Sterilization
Lost to Follow-Up
Advisory Committees
Hispanic Americans
Body Mass Index
Anti-Inflammatory Agents
Demography
Pharmaceutical Preparations

Keywords

  • Essure
  • Hysteroscopy
  • Office
  • Sterilization

ASJC Scopus subject areas

  • Obstetrics and Gynecology

Cite this

Prospective analysis of office-based hysteroscopic sterilization. / Levie, Mark D.; Chudnoff, Scott G.

In: Journal of Minimally Invasive Gynecology, Vol. 13, No. 2, 04.2006, p. 98-101.

Research output: Contribution to journalArticle

@article{25311c3911fc4e3a9c66c83867b14d12,
title = "Prospective analysis of office-based hysteroscopic sterilization",
abstract = "STUDY OBJECTIVES: To evaluate the efficacy of performing the Essure hysteroscopic sterilization in an office-based setting. DESIGN: Prospective, longitudinal analysis (Canadian Task Force classification II-3). SETTING: University out-patient office. PATIENTS: All patients undergoing permanent sterilization in our outpatient office who opted for hysteroscopic sterilization were included. INTERVENTIONS: Hysteroscopic placement of the Essure device in an office-based setting with only non-steroidal antiinflammatory drugs and paracervical block. MEASUREMENTS AND MAIN RESULTS: Multiple data points were collected on each patient including demographic data, specific procedural information, and 12-week hysterosalpingogram data. Most of our patients were Hispanic and had an average body mass index of 30.3. Average time to perform the procedure was 12.4 minutes, with the steepest improvement in the first 13 cases. Bilateral placement of the device was successful in 98 (96{\%}) of 102 patients. Of these patients 92 have 12-week hysterosalpingography results (6 patients were lost to follow-up), with 90 (98{\%}) showing bilateral tubal occlusion. There were no intraprocedural or postprocedural complications. CONCLUSION: In our institution and in our experience, office-hysteroscopic placement of the Essure device is a feasible and effective approach for permanent sterilization.",
keywords = "Essure, Hysteroscopy, Office, Sterilization",
author = "Levie, {Mark D.} and Chudnoff, {Scott G.}",
year = "2006",
month = "4",
doi = "10.1016/j.jmig.2005.11.010",
language = "English (US)",
volume = "13",
pages = "98--101",
journal = "Journal of Minimally Invasive Gynecology",
issn = "1553-4650",
publisher = "Elsevier",
number = "2",

}

TY - JOUR

T1 - Prospective analysis of office-based hysteroscopic sterilization

AU - Levie, Mark D.

AU - Chudnoff, Scott G.

PY - 2006/4

Y1 - 2006/4

N2 - STUDY OBJECTIVES: To evaluate the efficacy of performing the Essure hysteroscopic sterilization in an office-based setting. DESIGN: Prospective, longitudinal analysis (Canadian Task Force classification II-3). SETTING: University out-patient office. PATIENTS: All patients undergoing permanent sterilization in our outpatient office who opted for hysteroscopic sterilization were included. INTERVENTIONS: Hysteroscopic placement of the Essure device in an office-based setting with only non-steroidal antiinflammatory drugs and paracervical block. MEASUREMENTS AND MAIN RESULTS: Multiple data points were collected on each patient including demographic data, specific procedural information, and 12-week hysterosalpingogram data. Most of our patients were Hispanic and had an average body mass index of 30.3. Average time to perform the procedure was 12.4 minutes, with the steepest improvement in the first 13 cases. Bilateral placement of the device was successful in 98 (96%) of 102 patients. Of these patients 92 have 12-week hysterosalpingography results (6 patients were lost to follow-up), with 90 (98%) showing bilateral tubal occlusion. There were no intraprocedural or postprocedural complications. CONCLUSION: In our institution and in our experience, office-hysteroscopic placement of the Essure device is a feasible and effective approach for permanent sterilization.

AB - STUDY OBJECTIVES: To evaluate the efficacy of performing the Essure hysteroscopic sterilization in an office-based setting. DESIGN: Prospective, longitudinal analysis (Canadian Task Force classification II-3). SETTING: University out-patient office. PATIENTS: All patients undergoing permanent sterilization in our outpatient office who opted for hysteroscopic sterilization were included. INTERVENTIONS: Hysteroscopic placement of the Essure device in an office-based setting with only non-steroidal antiinflammatory drugs and paracervical block. MEASUREMENTS AND MAIN RESULTS: Multiple data points were collected on each patient including demographic data, specific procedural information, and 12-week hysterosalpingogram data. Most of our patients were Hispanic and had an average body mass index of 30.3. Average time to perform the procedure was 12.4 minutes, with the steepest improvement in the first 13 cases. Bilateral placement of the device was successful in 98 (96%) of 102 patients. Of these patients 92 have 12-week hysterosalpingography results (6 patients were lost to follow-up), with 90 (98%) showing bilateral tubal occlusion. There were no intraprocedural or postprocedural complications. CONCLUSION: In our institution and in our experience, office-hysteroscopic placement of the Essure device is a feasible and effective approach for permanent sterilization.

KW - Essure

KW - Hysteroscopy

KW - Office

KW - Sterilization

UR - http://www.scopus.com/inward/record.url?scp=33644750458&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33644750458&partnerID=8YFLogxK

U2 - 10.1016/j.jmig.2005.11.010

DO - 10.1016/j.jmig.2005.11.010

M3 - Article

C2 - 16527710

AN - SCOPUS:33644750458

VL - 13

SP - 98

EP - 101

JO - Journal of Minimally Invasive Gynecology

JF - Journal of Minimally Invasive Gynecology

SN - 1553-4650

IS - 2

ER -